UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services

UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services
UK Biocentre acts as the service arm of UK Biobank (Photo credit: UK Biocentre)
Advertisement img

UK Biocentre has been granted ISO 15189:2012 Accreditation by UKAS for sample processing and storage services. This landmark accreditation further extends UK Biocentre’s capabilities, increasing the scope of services it can provide to support clinical trials and studies, including DNA extraction.

To achieve this accreditation, UK Biocentre, the world-leading biomedical services and high-capacity biorepository provider, has demonstrated to UKAS that:

• it operates a proficient quality management system
• services are performed to the required standards
• and can therefore deliver clinically relevant data and results.

Featured Partners

UK Biocentre considers it a mark of confidence that underlines its dedication to delivering its services to the very highest quality standards.

Danielle Mulick, Head of Quality at UK Biocentre, said “UK Biocentre is already well known for sample processing and storage. This accreditation demonstrates our expertise to support a wide range of clinical trials and major clinical programmes. This success demonstrates that our unique experience and collaborative approach, combined with the amazing knowledge, standards, and skillset of our teams here at UK Biocentre, are recognised as truly industry leading.”

Dr. Tony Cox OBE, Chief Executive at UK Biocentre, said “Congratulations to all involved in getting us to this major milestone. It is a very important accreditation standard for UK Biocentre and opens doors to a new range of projects related to downstream clinical studies.”

UK Biocentre is a not-for-profit organization that provides large scale, fully automated biological sample processing and storage services to universities, the NHS, the government, and biotech companies. Its cost-effective sample processing and DNA/RNA extraction techniques can be scaled to suit a range of clinical studies.